Details of the Drug

General Information of Drug (ID: DM4MZXE)

Drug Name
Terodiline
Synonyms Bicor; Microl; Mictrol; Micturin; Micturol; Terolin; Terodiline hydrochloride; TD-758
Indication
Disease Entry ICD 11 Status REF
Urinary incontinence MF50.2 Phase 3 [1]
ATC Code
G04BD05: Terodiline
G04BD: Drugs for urinary frequency and incontinence
G04B: UROLOGICALS
G04: UROLOGICALS
G: GENITO URINARY SYSTEM AND SEX HORMONES
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 281.4
Logarithm of the Partition Coefficient (xlogp) 5
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 1
ADMET Property
Bioavailability
82% of drug becomes completely available to its intended biological destination(s) [2]
Clearance
The drug present in the plasma can be removed from the body at the rate of 1.1 mL/min/kg [3]
Half-life
The concentration or amount of drug in body reduced by one-half in 56 hours [3]
Unbound Fraction
The unbound fraction of drug in plasma is 0.08% [3]
Vd
Fluid volume that would be required to contain the amount of drug present in the body at the same concentration as in the plasma 5.1 L/kg [3]
Chemical Identifiers
Formula
C20H27N
IUPAC Name
N-tert-butyl-4,4-diphenylbutan-2-amine
Canonical SMILES
CC(CC(C1=CC=CC=C1)C2=CC=CC=C2)NC(C)(C)C
InChI
InChI=1S/C20H27N/c1-16(21-20(2,3)4)15-19(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,16,19,21H,15H2,1-4H3
InChIKey
UISARWKNNNHPGI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
23480
ChEBI ID
CHEMBL363295
CAS Number
15793-40-5
UNII
70KG06964W
DrugBank ID
DB13725
TTD ID
D0Y3ZP
INTEDE ID
DR1560
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

Molecular Interaction Atlas of This Drug


Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Cytochrome P450 3A4 (CYP3A4)
Main DME 		DE4LYSA CP3A4_HUMAN Substrate [4]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00002359) A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA)Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega. U.S. National Institutes of Health.
2 Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs by Using Various Cheminformatics Approaches
3 Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
4 Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions. Curr Pharm Biotechnol. 2012 Jul;13(9):1705-17.